Products

The patent covers Episurf Medical's 3D-based damage marking technology, central to the Episealer® implant system.

The new system debuts a lateral-specific tibia baseplate and an increased size range for femoral components and medial tibia baseplates.

The risk stratification tool intends to help surgeons transition more total joint arthroplasty cases to outpatient or same-day discharge.

The combination provides data to help surgeons determine optimal joint tension and implant sizing in reverse shoulder procedures.

The Smart SPACE digital platform gives real time feedback regarding implant positioning and is customized for every patient.

Preliminary results from a study of Episurf Medical's Episealer® Knee implant show good patient satisfaction and good knee function.

Episurf Medical received another Notice of Allowance for a U.S. patent that addresses devices and processes to facilitate treatment of joint lesions with osteochondral grafts.

Results from a clinical study of Episurf Medical's Episealer® Knee show good implant safety and significantly improved patient-reported outcome scores.

Study results indicate that use of Arthrosurface's OVO® with Inlay Glenoid Shoulder Arthroplasty System to treat glenohumeral OA yielded improved clinical outcomes, no reoperations or radiographic loosening and a high rate of return to activity.